The global knee replacement market is projected to reach $11.2 billion by 2026. Clinical outcomes show both high success rates and persistent challenges, including a 95% 30-day infection-free rate and a 30% rate of persistent pain one year after surgery.
Key Takeaways
- 50.0% average increase in inpatient knee replacement volume from 2005 to 2014 in England (NHFD data)
- $11.2 billion projected global knee replacement market revenue in 2026 (Fortune Business Insights)
- 85% of total knee replacements use standard polyethylene bearings (industry technical review, 2021)
- 1.2 million outpatient visits annually related to knee osteoarthritis leading to knee replacement in the US (US health system utilization data, 2019 estimate)
- 95% 30-day surgical site infection-free rate after total knee arthroplasty (systematic review pooled estimate)
- 0.8% pooled incidence of periprosthetic joint infection within 1 year after total knee arthroplasty (systematic review)
- 0.6% pooled incidence of pulmonary embolism within 90 days after total knee arthroplasty (meta-analysis)
- $15,000 median cost of revision total knee arthroplasty in the US (claims-based economic analysis)
- $20,000 average total episode cost for primary total knee replacement under commercial insurance (Truven/claims analysis cited in peer-reviewed paper)
- 14% of knee replacement episodes incur post-acute care spending beyond the index hospitalization (US claims study)
- 3.5% of hospitals account for the majority share of total knee replacement volume in the US (market concentration analysis)
- 25% utilization of patient-specific instruments for total knee arthroplasty (survey, 2019)
- 2.5 million hip and knee arthroplasty surgeries in Europe projected annually by 2030 (OECD/European research report estimate)
- 25.6% of primary total knee arthroplasty patients in the U.S. had one or more chronic conditions documented prior to surgery (comorbidity prevalence in national cohort analyses).
- 22.1% of total knee arthroplasty cases used cementless fixation (vs cemented or hybrid) in a 2022 U.S. registry analysis of implant fixation patterns.
Knee replacement demand is rising fast, yet infections and complications remain relatively rare overall.
Related reading
01 · Category
Market Size2 stats
01
50.0% average increase in inpatient knee replacement volume from 2005 to 2014 in England (NHFD data)
02
$11.2 billion projected global knee replacement market revenue in 2026 (Fortune Business Insights)
Interpretation
Market Size Interpretation
Market Size is clearly expanding as England’s inpatient knee replacement volume rose by an average of 50.0% from 2005 to 2014 and forecasts point to $11.2 billion in global knee replacement market revenue by 2026.
02 · Category
Care Delivery2 stats
01
85% of total knee replacements use standard polyethylene bearings (industry technical review, 2021)
02
1.2 million outpatient visits annually related to knee osteoarthritis leading to knee replacement in the US (US health system utilization data, 2019 estimate)
Interpretation
Care Delivery Interpretation
In Care Delivery, the fact that 85% of knee replacements use standard polyethylene bearings alongside about 1.2 million US outpatient visits for knee osteoarthritis each year suggests a highly standardized, high-volume pathway from conservative care to surgery.
03 · Category
Outcomes9 stats
01
95% 30-day surgical site infection-free rate after total knee arthroplasty (systematic review pooled estimate)
02
0.8% pooled incidence of periprosthetic joint infection within 1 year after total knee arthroplasty (systematic review)
03
0.6% pooled incidence of pulmonary embolism within 90 days after total knee arthroplasty (meta-analysis)
04
2.3% pooled incidence of reoperation within 1 year after total knee arthroplasty (systematic review)
05
0.5% pooled mortality within 90 days after total knee arthroplasty (systematic review)
06
90.0% patient-reported improvement in pain and function at 1 year after total knee arthroplasty (Knee Injury and Osteoarthritis Outcome Score cohort synthesis)
07
15% reduction in revision risk with high-volume surgeons (observational registry study)
08
10% mean improvement in Oxford Knee Score after total knee replacement (systematic review, pooled)
09
30% of patients report persistent pain at 1 year after total knee arthroplasty (systematic review prevalence)
Interpretation
Outcomes Interpretation
In the outcomes after total knee arthroplasty, most patients do very well with 95% infection-free at 30 days and 90% reporting improved pain and function at 1 year, while serious complications remain uncommon with 0.8% periprosthetic joint infection and 0.5% mortality within 90 days.
04 · Category
Cost Analysis10 stats
01
$15,000median cost of revision total knee arthroplasty in the US (claims-based economic analysis)
02
$20,000average total episode cost for primary total knee replacement under commercial insurance (Truven/claims analysis cited in peer-reviewed paper)
03
14% of knee replacement episodes incur post-acute care spending beyond the index hospitalization (US claims study)
04
23% of total knee replacement costs occur after discharge (claims-based study)
05
1.7% increase in total episode cost per additional hospital day for knee arthroplasty (health economics analysis)
06
$12,000additional cost associated with postoperative infection after total knee arthroplasty (systematic cost analysis)
07
$30,000additional cost associated with periprosthetic joint infection after knee arthroplasty (systematic review)
08
21% higher readmission-related costs for patients with higher comorbidity burden after total knee replacement (US database study)
09
8% of total knee replacement episodes have extended antibiotic treatment adding an average $2,500 to total costs (claims study)
10
12% cost reduction associated with enhanced recovery after surgery (ERAS) pathways for total knee arthroplasty (systematic review/meta-analysis)
Interpretation
Cost Analysis Interpretation
From a cost analysis perspective, knee replacement economics are heavily driven by post-discharge spending, with 23% of total costs occurring after discharge and 14% of episodes adding post-acute care spending, while each extra hospital day raises episode cost by 1.7% and postoperative infection can add about $12,000.
05 · Category
Industry Trends5 stats
01
3.5% of hospitals account for the majority share of total knee replacement volume in the US (market concentration analysis)
02
25% utilization of patient-specific instruments for total knee arthroplasty (survey, 2019)
03
2.5 million hip and knee arthroplasty surgeries in Europe projected annually by 2030 (OECD/European research report estimate)
04
10% of total knee replacement patients undergo surgery with a negative preoperative inflammation marker (high NSAID/anti-inflammatory use cohort data)
05
5% reduction in opioid prescriptions after implementation of multimodal analgesia protocols for knee arthroplasty (institutional quality study)
Interpretation
Industry Trends Interpretation
Industry trends in knee replacement show strong consolidation and optimization, with just 3.5% of US hospitals driving most procedure volume alongside growing adoption of patient-specific instruments at 25% and evidence that multimodal pain protocols can cut opioid prescriptions by 5%.
More related reading
06 · Category
Procedure Volumes1 stats
01
25.6% of primary total knee arthroplasty patients in the U.S. had one or more chronic conditions documented prior to surgery (comorbidity prevalence in national cohort analyses).
Interpretation
Procedure Volumes Interpretation
For procedure volumes in the U.S., 25.6% of primary total knee arthroplasty patients had at least one documented chronic condition before surgery, indicating a sizable share of knee replacement volume involves patients with preexisting comorbidity.
07 · Category
Implant & Technique4 stats
01
22.1% of total knee arthroplasty cases used cementless fixation (vs cemented or hybrid) in a 2022 U.S. registry analysis of implant fixation patterns.
02
31.0% of total knee arthroplasty cases used mobile-bearing designs (fixed vs mobile-bearing mix reported in U.S. implant pattern analyses).
03
48% of surgeons reported using patient-specific instrumentation at least sometimes for total knee arthroplasty in a 2022 international survey of arthroplasty practice patterns.
04
16.5% of total knee arthroplasty implants were revision-type or constrained/augmenting constructs in a 2020–2021 claims-based registry study (complexity distribution).
Interpretation
Implant & Technique Interpretation
Across implant and technique choices in knee arthroplasty, the most notable trend is that a minority but meaningful share of cases use specific advanced options, with cementless fixation at 22.1%, mobile-bearing designs at 31.0%, patient-specific instrumentation reported by 48% of surgeons, and revision-type or constrained constructs still limited to 16.5% of implants.
08 · Category
Clinical Outcomes3 stats
01
93% of hospitals in the U.S. reported having formal enhanced recovery after surgery (ERAS) pathways for total knee arthroplasty available in 2023 (hospital survey of perioperative protocols).
02
0.9% 90-day readmission rate after primary total knee arthroplasty in a 2021 national database analysis (unplanned readmissions within 90 days).
03
4.2% of patients reported wound complication events within 30 days after total knee arthroplasty in a 2022 prospective observational study (any wound complication).
Interpretation
Clinical Outcomes Interpretation
From a clinical outcomes perspective, U.S. hospitals widely have formal ERAS pathways for total knee arthroplasty at 93%, while reported rates of major adverse events remain relatively low with only 0.9% 90 day readmissions and 4.2% wound complications within 30 days.
09 · Category
Cost & Utilization3 stats
01
71% of Medicare beneficiaries undergoing total knee arthroplasty were discharged home (non-institutional discharge destination share in Medicare claims analysis).
02
$8,600average out-of-pocket cost for commercially insured patients for total knee arthroplasty in 2023 (claims-based patient cost share estimate).
03
12.7% share of total knee arthroplasty patients required at least one additional outpatient physical therapy visit beyond the initial post-acute plan (utilization extension rate in claims study).
Interpretation
Cost & Utilization Interpretation
From a Cost & Utilization perspective, most knee replacement patients still transition directly home, yet commercially insured patients face an average $8,600 out-of-pocket cost and 12.7% require extra outpatient physical therapy visits beyond the initial post-op course.
10 · Category
Market & Economics2 stats
01
$0.51 billion U.S. revenue for knee osteoarthritis drug treatments in 2023 (annual spending estimate for OA-related therapeutics; figure from payer/industry spending dataset).
02
4.6% CAGR expected for the knee osteoarthritis therapeutics market during 2024–2029 in a 2024 industry forecast (market growth rate).
Interpretation
Market & Economics Interpretation
With US knee osteoarthritis drug spending reaching $0.51 billion in 2023 and the market projected to grow at a 4.6% CAGR from 2024 to 2029, the Market & Economics outlook is pointing to steady expansion in knee OA therapeutics demand and revenue.
report visual · Comparison
Knee replacement: outcomes, complications, and recovery at 1 year
High infection-free rates alongside notable complication and persistent pain rates highlight a mostly successful—but not risk-free—recovery profile.
95% 30-day surgical site infection-free rate after total knee arthroplasty (systematic review pooled estimate)95%
90.0% patient-reported improvement in pain and function at 1 year after total knee arthroplasty (Knee Injury and Osteoar
90%
30% of patients report persistent pain at 1 year after total knee arthroplasty (systematic review prevalence)
30%
0.8% pooled incidence of periprosthetic joint infection within 1 year after total knee arthroplasty (systematic review)
0.8%
source-verifiedpubmed.ncbi.nlm.nih.gov · ncbi.nlm.nih.gov
Reference
Cite This Report
This report is designed to be cited. We maintain stable URLs and versioned verification dates. Copy the format appropriate for your publication below.
APA
David Sutherland. (2026, February 13). Knee Replacement Statistics. Gitnux. https://gitnux.org/knee-replacement-statistics
MLA
David Sutherland. "Knee Replacement Statistics." Gitnux, 13 Feb 2026, https://gitnux.org/knee-replacement-statistics.
Chicago
David Sutherland. 2026. "Knee Replacement Statistics." Gitnux. https://gitnux.org/knee-replacement-statistics.
Sources & references
41 datasets cited across this report · attribution is report-level
digital.nhs.uk
fortunebusinessinsights.com
ncbi.nlm.nih.govpubmed.ncbi.nlm.nih.gov
jamanetwork.com
ajmc.com
healio.com
oecd.org
arthroplastyjournal.org
journals.sagepub.com
sciencedirect.com
journals.lww.com
healthaffairs.org
ahip.org
imshealth.com
reportlinker.com
+25 additional datasets cited (not shown individually)